ReviewFrontiers in immunology2018
Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression.
Viktor Fleming et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
287 papers cite itlatest 60 shown
this paperpooled itcites it